simplify and abbreviate a PCT
Name: GNRH Triptorelin Peptide Magnus Pharmaceuticals
Active ingredient: 2mg GNRH Triptorelin Magnus Pharmaceuticals. Triptorelin can be an effective way to “kickstart” the body’s testosterone production or, in general, to simplify and abbreviate a PCT.
By buying this product you can collect up to 4 loyalty points. Your cart will total 4 loyalty points that can be converted into a voucher of 0,80 €.
GNRH Triptorelin Peptide Magnus Pharmaceuticals can be an effective way to „kickstart“ the body‘s testosterone production at exact doses after a steroid (anabolic) cure. Or generally a PCT simplify and abbreviate.
GNRH Triptorelin Peptide Magnus Pharmaceuticals is a synthetic analogue to the so-called gonadotropin releasing hormone (GnRH or gonadoliberin) and acts as a GnRH agonist. Triptorelin ensures that the pituitary gland distributes smaller amounts of the hormones LH and FSH. This has the direct consequence that the secretion of sex hormones such as testosterone is stimulated. Reduced by long-term use of triptorelin (more than 2 weeks).
In the normal case, GNRH uses triptorelin Magnus Pharmaceuticals for the treatment of various types of cancer, such as prostate cancer, or for the treatment of sexual identity disorders. Or can be applied to women in advance of artificial insemination in order to increase the chances of success.
For use as a means for PCT or for a complete restart of testosterone production after a shutdown. For which this peptide is also interesting, GNRH Triptorelin Peptide Magnus Pharmaceuticals should not be overdosed (maximum 100 mcg), since otherwise it can be very likely that a (temporary) chemical castration occurs.
In general, GnRH agonists (such as triptorelin, sequence: pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2) are used when the end of the target is a reduction in the amount of sex hormones circulating in the body Therapeutic reasons. This is the case, for example, with certain types of cancer, such as breast cancer or prostate cancer. GnRH agonists force the hypophysis to release hormones FSH (follicular stimulating hormone) and LH (luteinizing hormone) in excessive amounts. This mechanism first leads to excessive secretion of sex hormones such as estrogen or testosterone (whose secretion is influenced by FSH and LH, respectively) until the pituitary gland has exhausted its natural supply of FSH and LH due to overstimulation, leading to sustained lower serum levels of these sex hormones leads.
GnRH agonists such as GNRH Triptorelin Peptide Magnus Pharmaceuticals are not only used for hormone-dependent cancer. Also with early puberty in children, with gender identity disturbances or also in the framework of artificial fertilizations, GNRH Triptorelin Peptide Magnus Pharmaceuticals is frequently used. Therefore, GNRH Triptorelin Peptide Magnus Pharmaceuticals is also a substance whose effects and side effects have been well explored for many years.
But even in the case of really well researched substances, scientists sometimes find interesting new applications that were not originally thought of.
Italian specialist article shows: With only one application, Triptorelin was able to normalize the testosterone values of a longtime steroid user!
The article titled „Anabolic steroids on the Internet as a cause of prolonged hypogonadotropic hypogonadism“, published in November 2010 in the journal Fertility & Sterility, shows how Italian endocrinologists from the University of Brescia help a 34-year-old male steroid user with complete testosterone shutdown by means of triptorelin could.
The man had regularly taken steroids such as nandrolone, boldenone or stanozole since he was 21 years old, and he also carried out inadequate PCT‘s.
Therefore he went to his house doctor in September 2008 and complained about depression, chronic exhaustion and loss of libido as well as potency problems.
The physician referred his patients to the endocrinologists of the University of Brescia who examined the man‘s blood tests and then decided to observe the situation for several months. In January 2009, they were unable to detect any significant improvement in the testosterone level when testing new blood levels, suggesting that the patient‘s body-borne testosterone production had almost completely ceased. The endocrinologists then decided to treat with triptorelin and gave the patient a single injection of 100 mcg of triptorelin.
The patient immediately responded to treatment with triptorelin and within a few minutes the serum levels of FSH and LH increased in his blood.
At a control appointment 10 days later, the endocrinologists were able to establish that the patient was completely healthy and alert. His serum concentration of testosterone was now 7 ng / ml while it was just 1.7 ng / ml before treatment with triptorelin and was only 0.3 ng / ml in September 2008. Even after a further 3 weeks, the serum concentration of the testosterone was still within the normal range during another control study. In this way it could be demonstrated that triptorelin can effectively restart the secretion of testosterone in intensive steroid users with complete or almost complete stop of the body-specific testosterone production.
The dosage and correct use of GNRH Triptorelin Peptide Magnus Pharmaceuticals for use as a PCT or as a means of correcting a testosterone shutdown. As noted above, GNRH Triptorelin Peptide Magnus Pharmaceuticals is a means to restart testosterone production, or as a means to perform a PCT, requires only one injection at a dose of 100mcg.
GNRH Triptorelin Peptide Magnus Pharmaceuticals stimulates the hypophysis too much at higher doses, so that the secretion of sex hormones by the body is set much faster. If the use of GNRH Triptorelin Peptide Magnus Pharmaceuticals is planned after a steroid cycle, the injection should only be carried out two weeks after discontinuation of the steroids.
At higher doses of 2 to 4 mg once a month, GNRH Triptorelin Peptide Magnus Pharmaceuticals can also be used as a means of long-term chemical castration. Which for most readers, however, should not be an attractive application. If one wants to use GNRH Triptorelin Peptide Magnus Pharmaceuticals as a means for the PCT, an injection of 100 mcg GNRH Triptorelin Peptide Magnus Pharmaceuticals is sufficient.
If you want to carry out a PCT more than once in one year and plan to use GNRH Triptorelin Peptide Magnus Pharmaceuticals. Should be between the individual applications a period of at least 4 months. One should never inject more than 300 mcg of GNRH Triptorelin Peptide Magnus Pharmaceuticals (max. 100 mcg every 4 months) per year as otherwise the risk of a drop in the serum concentration of testosterone to catastrophic values is higher at higher doses.
If you want to perform a PCT with GNRH Triptorelin Peptide Magnus Pharmaceuticals, you should not use SERMs like clomifene, raloxifene or tamoxifen. Also hCG should not be used simultaneously with GNRH Triptorelin Peptide Magnus Pharmaceuticals. Ordinary testosterone boosters, e.g. DAA can be administered as usual in the weeks following the GNRH Triptorelin Peptide Magnus Pharmaceuticals injection.
For the reconstitution of the peptide normally present as a lyophilized powder, use can be made of sterile water. Since the reconstituted solution does not have to be stored but is injected directly at once. As a rule, only sterile water has to be introduced into the vial in such a way that the reconstituted triptorelin solution resulting from it can completely fill the standing cannula for the injection. Normally 1 to 2 ml of sterile water should be sufficient.
GNRH Triptorelin Peptide Magnus Pharmaceuticals is a peptide which, due to its strong influence on the hormone system of the human body, can have some side effects, even if the number of side-effects actually occurring should be very limited.
All the side effects listed below only occur when GNRH Triptorelin Peptide Magnus Pharmaceuticals is used in the long term and therefore the human organism is exposed to a higher dose:
Essentially, these side effects are only listed here if someone is looking for the side effects of GNRH Triptorelin Peptide Magnus Pharmaceuticals for longer-term use and these are not relevant for the target group actually addressed here.